logo_ProQR-150x150.png
ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference
24 oct. 2017 07h00 HE | ProQR Therapeutics N.V.
LEIDEN, the Netherlands, Oct. 24, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...